Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
783,412
-
Shares change
-
+7,223
-
Total reported value, excl. options
-
$157,963,396
-
Value change
-
+$1,508,438
-
Put/Call ratio
-
17.8%
-
Number of buys
-
39
-
Number of sells
-
-33
-
Price
-
$201.66
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2021
121 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q2 2021.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 783,412 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (116,612 shares), MORGAN STANLEY (62,810 shares), ROYAL BANK OF CANADA (53,673 shares), UBS Group AG (42,465 shares), MURPHY CAPITAL MANAGEMENT INC (33,750 shares), BANK OF AMERICA CORP /DE/ (31,811 shares), Kestra Advisory Services, LLC (30,842 shares), MOGY JOEL R INVESTMENT COUNSEL INC (29,417 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (24,376 shares), and LPL Financial LLC (22,227 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.